Washington Trust Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AAMU
FMI
DSA
Washington Trust Bank's DGX Position: Q2 2019 in Review
Washington Trust Bank sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 500 shares — an estimated $45K sold.
Washington Trust Bank first reported a position in DGX in Q1 2014 and held it in 21 quarters. The position peaked at $77K in Q2 2018. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.
- Washington Trust Bank reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
- Washington Trust Bank sold 500 Quest Diagnostics shares in Q2 2019, an estimated $45K.
- Washington Trust Bank first reported a position in Quest Diagnostics in Q1 2014 and held it in 21 quarters.
- Washington Trust Bank's Quest Diagnostics position peaked at $77K in Q2 2018.
- 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.
Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.